Perrault David P, Sharma Ayushi, Kim Jessica F, Gurtner Geoffrey C, Wan Derrick C
Hagey Laboratory for Pediatric Regenerative Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.
Division of Plastic and Reconstructive Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA 94305, USA.
Bioengineering (Basel). 2022 Mar 26;9(4):138. doi: 10.3390/bioengineering9040138.
The infection of surgically placed implants is a problem that is both large in magnitude and that broadly affects nearly all surgical specialties. Implant-associated infections deleteriously affect patient quality-of-life and can lead to greater morbidity, mortality, and cost to the health care system. The impact of this problem has prompted extensive pre-clinical and clinical investigation into decreasing implant infection rates. More recently, antimicrobial approaches that modify or treat the implant directly have been of great interest. These approaches include antibacterial implant coatings (antifouling materials, antibiotics, metal ions, and antimicrobial peptides), antibacterial nanostructured implant surfaces, and antibiotic-releasing implants. This review provides a compendium of these approaches and the clinical applications and outcomes. In general, implant-specific modalities for reducing infections have been effective; however, most applications remain in the preclinical or early clinical stages.
外科植入物的感染是一个规模庞大且广泛影响几乎所有外科专业的问题。与植入物相关的感染会对患者生活质量产生有害影响,并可能导致更高的发病率、死亡率以及医疗系统成本增加。这一问题的影响促使人们对降低植入物感染率进行了广泛的临床前和临床研究。最近,直接对植入物进行改性或治疗的抗菌方法引起了极大关注。这些方法包括抗菌植入物涂层(防污材料、抗生素、金属离子和抗菌肽)、抗菌纳米结构植入物表面以及抗生素释放植入物。本综述提供了这些方法以及临床应用和结果的概要。总体而言,针对减少感染的特定植入物方式已证明有效;然而,大多数应用仍处于临床前或早期临床阶段。